Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Cornea
Share your love
Meeting expectations with evolving technology
(Image Credit: AdobeStock) As an ophthalmology resident, I am increasingly meeting patients who underwent LASIK surgery 15 or 20 years ago. They were the early adopters of refractive surgery, thrilled to toss their glasses in their youth. Now in their…
CU Ophthalmology Researchers Investigate How Human Breast Milk May Help Heal Cornea Wounds – CU Anschutz newsroom
CU Ophthalmology Researchers Investigate How Human Breast Milk May Help Heal Cornea Wounds CU Anschutz newsroom Source: Author: | Date: 2025-02-06 08:00:00 Source: Author: | Date: 2025-02-06 08:00:00
Zeiss Completes Acquisition of DORC
In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…
Pantheon Vision Gets Another $1.8M for Corneal Implants
Pantheon Vision, a pioneering medical device company in the pre-clinical stage focused on developing bioengineered corneal implants, has secured an additional $1.8 million in funding. This recent financial boost is part of a second tranche from KeraLink International (KLI), following…
Alcon Names Terry Kim, MD as Chief Medical Officer
Alcon announced the appointment of Terry Kim, MD, as the company’s new Chief Medical Officer (CMO) and Head of Global Medical Safety, starting in April. Dr. Kim, a renowned figure in the field of ophthalmology, brings a wealth of experience…
Aurion’s First Canadian Dose in Corneal Edema Trial
Aurion Biotech has dosed the first Canadian participant in its phase 1/2 clinical trial, known as ABA-1, CLARA. The trial investigates the efficacy and safety of AURN001, a novel cell therapy aimed at treating corneal edema resulting from corneal endothelial…
Provectus & University of Miami Ink Deal on Eye Treatment
Provectus Biopharmaceuticals, Inc. has signed an exclusive global licensing agreement with the University of Miami. This partnership aims to harness the University’s pioneering photodynamic antimicrobial therapy (PDAT) for combating bacterial, fungal, and parasitic (acanthamoeba) eye infections. Launching a Start-Up for…
10 Signs to Consider Glasses or New Prescriptions
Vision is a critical aspect of our daily lives, enabling us to navigate our environment, engage in activities, and enjoy the beauty of the world around us. However, our eyesight can change over time, often gradually enough that we might…
CorNeat Vision Introduces CorNeat EverPatch in the U.S.
CorNeat Vision has launched the CorNeat EverPatch in the United States, a novel synthetic tissue-integrating matrix poised to transform ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device marks a significant advancement in addressing complications associated with…
Amring Names Dr. Donnenfeld as U.S. Advisory Board Chair
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…